Skip to main content

Advertisement

SpringerLink
Log in

Cytoreductive Surgery in Combination with HIPEC in the Treatment of Peritoneal Sarcomatosis

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an effective treatment for peritoneal carcinomatosis, but it has been debated for peritoneal sarcomatosis. The purpose of the study is the presentation of perioperative and long-term results of CRS and hyperthermic intraoperative intraperitoneal chemotherapy in patients with peritoneal sarcomatosis. Retrospective study in a prospectively maintained database of 20 patients that underwent 29 CRS + HIPEC for peritoneal sarcomatosis. Clinical and histopathologic variables were correlated to survival. Complete cytoreduction was possible in 86.2% of the cases. The hospital mortality and morbidity rate were 0 and 20.7%, respectively. The median follow-up was 26 months, and recurrence was recorded in 20 cases (69%). The median and 5-year survival was 55 ± 13 (34–58) months and 43%, respectively. Prior surgical score (PSS) was the single variable related to survival (p = 0.018). The histologic subtype of the tumor was related to recurrence (p < 0.001). CRS and HIPEC in peritoneal sarcomatosis may offer a survival benefit in selected patients with low hospital mortality. The variety of histologic types of sarcomatosis has not made possible the identification of subgroups of patients that may be offered significant benefit by CRS and HIPEC. Further studies are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Singer S, Maki RG, O’ Sullivan B (2009) Soft tissue sarcoma. In: De Vita VT, Lawrence TS, Rosenberg SA et al (eds) Cancer: principles and practice of oncology. Wolters Kluwer Health/Lippincott Williams and Wilkins, Philadelphia, pp 1533–1577

    Google Scholar 

  2. Sugarbaker PH (1996) Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy. In: Sugarbaker P (ed) Peritoneal carcinomatosis: drugs and diseases. Kluwer Academic Publishers, Boston, pp 149–168

    Chapter  Google Scholar 

  3. Bilimoria MM, Holtz DJ, Mirza NQ, Feig BW, Pisters PWT, Patel S, Pollock RE, Benjamin RS, Papadopoulos NE, Plager C, Murphy A, Griffin JR, Burgess MA, Hunt KK (2002) Tumor volume as a prognostic factor for sarcomatosis. Cancer 94:2441–2446

    Article  PubMed  Google Scholar 

  4. Ferrario T, Karakousis CP (2003) Retroperitoneal sarcomas: grade and survival. Arch Surg 138:248–251

    Article  PubMed  Google Scholar 

  5. Baumgartner JM, Ahrendt SA, Pingpank J et al (2013) Aggressive locoregional management of recurrent peritoneal sarcomatosis. J Surg Oncol 107:329–334

    Article  CAS  PubMed  Google Scholar 

  6. Yan TD, Black D, Savady R, Sugarbaker PH (2006) Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24:4011–4019

    Article  PubMed  Google Scholar 

  7. Yan TD, Black D, Savady R, Sugarbaker PH (2007) A systematic review on the efficacy of cytoreductive surgery combined and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14:484–492

    Article  PubMed  Google Scholar 

  8. Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D, French Surgical Association (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer 116:5608–5618

    Article  PubMed  Google Scholar 

  9. Yan TD, Brun EA, Cerruto CA, Haveric N, Chang D, Sugarbaker PH (2006) Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 14:41–49

    Article  PubMed  Google Scholar 

  10. Munene G, Mack LA, Temple WJ (2011) Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy. Ann Surg Oncol 18:207–213

    Article  PubMed  Google Scholar 

  11. Bryan ML, Fitzgerald NC, Levine EA, Shen P, Stuart GH, Votanopoulos K (2014) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in sarcomatosis from gastrointestinal stromal tumor. Am Surg 80:890–895

    PubMed  PubMed Central  Google Scholar 

  12. Sugarbaker PH, Chang D, Koslowe P (1996) Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy. In: Sugarbaker P (ed) Peritoneal carcinomatosis: drugs and diseases. Kluwer Academic Publishers, Boston, pp 89–104

    Chapter  Google Scholar 

  13. Sugarbaker PH (1996) Peritonectomy procedures. Cancer Treat Res 82:235–253

    Article  CAS  PubMed  Google Scholar 

  14. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sugarbaker PH (2001) Review of a personal experience in the management of carcinomatosis and sarcomatosis. Jpn J Clin Oncol 31:573–583

    Article  CAS  PubMed  Google Scholar 

  16. Randle RW, Swett KR, Shen P, Stewart JH, Levine EA, Votanopoulos K (2013) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis. Am Surg 79:620–624

    PubMed  PubMed Central  Google Scholar 

  17. Karakousis CP, Blumenson LE, Cavanese G et al (1992) Surgery for disseminated abdominal sarcoma. Am J Surg 163:560–564

    Article  CAS  PubMed  Google Scholar 

  18. Bonvalot S, Cavalcanti A, Le Pechoux C et al (2005) Ramdomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol 31:917–923

    Article  CAS  PubMed  Google Scholar 

  19. Elias D, Benizri E, Di Pietrantonio D, Menegon P, Malka D, Raynard B (2006) Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 14:509–514

    Article  PubMed  Google Scholar 

  20. Baratti D, Pennacchioli E, Kusamura S, Fiore M, Balestra MR, Colombo C, Mingrone E, Alessanrdro G, Deraco M (2010) Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol 17:3220–3228

    Article  PubMed  Google Scholar 

  21. Rossi CR, Deraco M, De Simone M et al (2004) Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer 100:1943–1950

    Article  PubMed  Google Scholar 

  22. Berthet B, Sugarbaker TA, Chang D, Sugarbaker PH (1999) Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 35:413–419

    Article  CAS  PubMed  Google Scholar 

  23. Kusamura S, Deraco M, Baratti D, Inglese MG, Costanzo P, Favaro M, Manzi R, Gavazzi C (2003) Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique. J Exp Clin Cancer Res 22(4 Suppl):207–212

    CAS  PubMed  Google Scholar 

  24. Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin RS, Griffin JR, Chase JL, Pisters PWT, Pollock RE, Hunt KK (2007) Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol 14:2309–2318

    Article  PubMed  Google Scholar 

  25. Sardi A, Jimenez W, Nieroda C, Sittig M, Shankar S, Gushichin V (2014) Melphalan: a promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 21:908–914

    Article  PubMed  Google Scholar 

  26. Sugarbaker PH, Ihemelandu C, Bijelic L (2015) Cytoreductive and HIPEC as a treatment option for laparoscopic resection of uterine leiomyosarcoma with morcellation: early results. Ann Surg. https://doi.org/10.1245/s10434-015-4960-y

  27. Tentes AA, Kakolyris S, Kyziridis D, Karamveri C (2012) Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer. J Oncol 2012:358341

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology, Peritoneal Surface Malignancy Program, Metropolitan Hospital, Venizelou 1, 18547, New Faliro, Greece

    Christina Karamveri, Nicolaos Pallas, Vasileios Kyriakopoulos & Antonios-Apostolos K. Tentes

  2. Surgical Oncology, Peritoneal Surface Malignancy Program, Euromedica, Kyanous Stavros, Viziis 1, 54636, Thessaloniki, Greece

    Dimitrios Kyziridis, Christos Hristakis, Apostolos Kalakonas, Dimitrios Vaikos & Antonios-Apostolos K. Tentes

Authors
  1. Christina Karamveri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicolaos Pallas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dimitrios Kyziridis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christos Hristakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vasileios Kyriakopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Apostolos Kalakonas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dimitrios Vaikos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Antonios-Apostolos K. Tentes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonios-Apostolos K. Tentes.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karamveri, C., Pallas, N., Kyziridis, D. et al. Cytoreductive Surgery in Combination with HIPEC in the Treatment of Peritoneal Sarcomatosis. Indian J Surg Oncol 10, 40–45 (2019). https://doi.org/10.1007/s13193-018-0782-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-018-0782-2

Keywords

Search

Navigation